MyJournals Home  

RSS FeedsEffectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study (BMC Pulmonary Medicine)

 
 

3 may 2021 19:27:40

 
Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study (BMC Pulmonary Medicine)
 


Pirfenidone is an anti-fibrotic agent shown to slow the progression of idiopathic pulmonary fibrosis (IPF). However, its effectiveness in association with serological autoimmune features in IPF remains unclear.


 
61 viewsCategory: Medicine
 
The value of transbronchial lung biopsy in the diagnosis of lymphangioleiomyomatosis (BMC Pulmonary Medicine)
Severe COVID-19 in the intensive care unit: a case series (Journal of Medical Case Reports)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Medicine


Copyright © 2008 - 2021 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten